[1]
R. TANJUNG, Y. WARDATI, and N. M. SAPTARINI, “COST-EFFECTIVENESS ANALYSIS OF PROLANIS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THREE COMMUNITY HEALTH CENTERS IN BANDUNG, INDONESIA”, Int J App Pharm, vol. 13, no. 3, pp. 28–31, Mar. 2021.